Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK

Mortality from cardiogenic shock attributable to acute myocardial infarction (AMI) approaches 50%, a figure that has not significantly improved in recent years. One of the only interventions found to improve mortality is urgent reperfusion of the culprit artery. However, 70% to 80% of patients with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of internal medicine (1960) 2020-10, Vol.180 (10), p.1280-1283
Hauptverfasser: DeJong, Colette, Redberg, Rita F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mortality from cardiogenic shock attributable to acute myocardial infarction (AMI) approaches 50%, a figure that has not significantly improved in recent years. One of the only interventions found to improve mortality is urgent reperfusion of the culprit artery. However, 70% to 80% of patients with ischemic cardiogenic shock have multivessel coronary artery disease, and optimal management of nonculprit lesions has been unclear.
ISSN:2168-6106
2168-6114
DOI:10.1001/jamainternmed.2020.3400